Early changes in hepatitis C virus (HCV) RNA levels predict response to interferon treatment in noncirrhotic HCV patients.

Fallows, G; Kaita, K; Minuk, G; Penner, F; Smart, G; Dawood, M; Rosser, B

Fallows, G; Kaita, K; Minuk, G; Penner, F; Smart, G; Dawood, M; Rosser, B.

Affiliation

Fallows G; Liver Diseases Unit, University of Manitoba, Winnipeg, Canada.

Can J Gastroenterol ; 14 Suppl B: 30B-35B, 2000.

Article in En | MEDLINE | ID: mdl-10938502

Subject(s)

Antiviral Agents/therapeutic use; Hepacivirus/genetics; Hepatitis C, Chronic/drug therapy; Interferon-alpha/therapeutic use; RNA, Viral/metabolism; Adult; Age Factors; Alanine Transaminase/blood; Antiviral Agents/administration & dosage; Cost Savings; Female; Hepatitis C, Chronic/virology; Humans; Interferon-alpha/administration & dosage; Male; Sensitivity and Specificity; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / RNA, Viral / Interferon-alpha / Hepacivirus / Hepatitis C, Chronic Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Can J Gastroenterol Journal subject: GASTROENTEROLOGIA Year: 2000 Type: Article Affiliation country: Canada

Search on Google

XML

PubMed Links